CAT introduces ‘novel’ trial procedure in pharma excessive pricing appeals

The UK’s Competition Appeal Tribunal has introduced a new trial procedure as drugmakers appeal against two excessive pricing decisions from the UK’s antitrust enforcer, asking the parties involved to prepare parts of a pretrial draft judgment that contains all non-contentious facts.

Get unlimited access to all Global Competition Review content